Chugai Pharmaceutical Co Stock Performance
| CHGCF Stock | USD 33.27 5.87 15.00% |
The firm shows a Beta (market volatility) of 0.66, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Chugai Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Chugai Pharmaceutical is expected to be smaller as well. Chugai Pharmaceutical has an expected return of -0.12%. Please make sure to confirm Chugai Pharmaceutical skewness, as well as the relationship between the rate of daily change and price action indicator , to decide if Chugai Pharmaceutical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Chugai Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's fundamental indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
| Begin Period Cash Flow | 212.3 B | |
| Total Cashflows From Investing Activities | -118.9 B |
Chugai |
Chugai Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 3,700 in Chugai Pharmaceutical Co on January 19, 2024 and sell it today you would lose (373.00) from holding Chugai Pharmaceutical Co or give up 10.08% of portfolio value over 90 days. Chugai Pharmaceutical Co is currently producing negative expected returns and takes up 3.0659% volatility of returns over 90 trading days. Put another way, 27% of traded pink sheets are less volatile than Chugai, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Chugai Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chugai Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Chugai Pharmaceutical Co, and traders can use it to determine the average amount a Chugai Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0397
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CHGCF |
Estimated Market Risk
| 3.07 actual daily | 27 73% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Chugai Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chugai Pharmaceutical by adding Chugai Pharmaceutical to a well-diversified portfolio.
Chugai Pharmaceutical Fundamentals Growth
Chugai Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Chugai Pharmaceutical, and Chugai Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chugai Pink Sheet performance.
| Return On Equity | 0.29 | |||
| Return On Asset | 0.2 | |||
| Profit Margin | 0.30 % | |||
| Operating Margin | 0.42 % | |||
| Current Valuation | 39.67 B | |||
| Shares Outstanding | 1.64 B | |||
| Price To Earning | 19.49 X | |||
| Price To Book | 3.95 X | |||
| Price To Sales | 0.04 X | |||
| Revenue | 999.76 B | |||
| EBITDA | 419.43 B | |||
| Cash And Equivalents | 545.3 B | |||
| Cash Per Share | 331.48 X | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 865.88 X | |||
| Cash Flow From Operations | 279.63 B | |||
| Earnings Per Share | 1.71 X | |||
| Total Asset | 1.54 T | |||
| Retained Earnings | 500.19 B | |||
| Current Asset | 542.89 B | |||
| Current Liabilities | 107.7 B | |||
About Chugai Pharmaceutical Performance
To evaluate Chugai Pharmaceutical Pink Sheet as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Chugai Pharmaceutical generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Chugai Pink Sheet's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Chugai Pharmaceutical market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Chugai's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. Chugai Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 7664 people.Things to note about Chugai Pharmaceutical performance evaluation
Checking the ongoing alerts about Chugai Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Chugai Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Chugai Pharmaceutical generated a negative expected return over the last 90 days | |
| Chugai Pharmaceutical has high historical volatility and very poor performance | |
| About 60.0% of the company shares are held by company insiders |
- Analyzing Chugai Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chugai Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Chugai Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chugai Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chugai Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chugai Pharmaceutical's pink sheet. These opinions can provide insight into Chugai Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chugai Pharmaceutical Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Chugai Pharmaceutical information on this page should be used as a complementary analysis to other Chugai Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Chugai Pink Sheet analysis
When running Chugai Pharmaceutical's price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |